Introduction
Venous complications of cardiac implantable electronic devices rarely cause immediate clinical problems; however, a fraction of patients develops severe stenosis or occlusion of the deep veins of an upper extremity. 1 It was reported that subclavian vein obstruction in patients with pacemaker leads is not uncommon, occurring in 13-35% of patients. 2 When upgrading a pacemaker system to a cardiac resynchronization therapy pacemaker (CRT-P) or cardiac resynchronization therapy defibrillator (CRT-D), such obstructions can make the implantation of new pacemaker leads difficult. Herein, we report two cases in which upgrading to CRT-P was challenging due to total central vein occlusion. In the first case, a 78-year-old woman was successfully treated by balloon venoplasty. In the second case, balloon venoplasty was unsuccessful in a 46-yearold woman due to vessel crowding, so a contralateral side puncture, along with a tunnel technique, was performed to solve this problem.
Learning points
• Carefully inspect venography before the procedure is important, especially presence of previous cardiac implantable electronic device. • If stenosis exists, balloon angioplasty, previous leads extraction, or contralateral implantation can be an option.
• Following proposed treatment algorithm, implanting physicians can manage implantation logically.
Timeline Case presentation
Illustrative case no. 1
A 78-year-old woman with congestive heart failure with left ventricular ejection fraction (LVEF): 40% was diagnosed with complete atrioventricular node block after implantation of a permanent pacemaker in DDD mode (Biotronik) on 6 May 2014. There was no other past medical history in this patient. She presented with dyspnoea on exertion that had been occurring for 1 year. The physical examination revealed third heart sound, bilateral rales, and peripheral oedema, and the chest X-ray revealed bilateral pulmonary oedema. Heart failure with a reduced EF of 24% was noted and designated as Class III according to the New York Heart Association system. She was administered with optimal medication for heart failure (Ramipril 10 mg bid, Carvedilol 25 mg bid, Spironolactone 50 mg od, and Furosemide 40 mg od). A 12-lead electrocardiogram (ECG) showed a ventricular pacing rhythm with QRS duration >150 ms. To remedy this problem, she was admitted for a CRT upgrade.
As shown in Figure 1A , venography demonstrated total vessel occlusion, with azygos vein collateral drainage with the previous two leads. We punctured as far as the occlusion site and inserted a 0.035-in Terumo wire (Terumo Corporation, Tokyo, Japan), but could not move the wire past the lesion, even after switching to a V18 control wire (Boston Scientific, Boston, MA, USA), because the wire was not stiff enough. We then inserted a 5-Fr short sheath (Terumo) and performed balloon venoplasty using a Mustang balloon (6.0/40 mm, Boston Scientific). A stiffer guidewire (Terumo) was used simultaneously to advance an 8-Fr long sheath past the lesion under the support of a 9-Fr short sheath. The left ventricular (LV) lead (Medtronic, Dublin, Ireland) was implanted without difficulty. The total fluoroscopy time was 40 min, and total procedure time was 110 min. The ECG showed a narrow QRS pattern with duration of 88 min. The patient was discharged without incident, and a 3-month follow-up echocardiogram showed preserved LVEF of 62% and sinus rhythm with narrow QRS in an ECG. At a routine pacemaker programming visit, the condition of the leads was stable and all parameters were normal. The patient's symptoms had also improved.
Illustrative case no. 2
A 46-year-old woman had a history of dilated cardiomyopathy with a reduced LVEF of 30% and sustained ventricular tachycardia Performed cardiac resynchronization therapy (CRT) upgrade due to symptomatic heart failure in sinus rhythm with a QRS duration > _150 ms, LBBB QRS morphology and with LVEF < _35% despite optimal medication Follow-up Classified as Class I according to the New York Heart Association system ECG: sinus rhythm with narrow QRS Figure 2A) . We successfully cannulated the coronary sinus ostium and implanted a bipolar LV lead (Medtronic).
Unfortunately, the right atrium (RA) lead could not pass through the limited space of the left subclavian vein ( Figure 2B and C) , even after successful balloon angioplasty using a Terumo 0.035 wire and a Mustang balloon (4.0/60 mm). The patient refused both replacement of the device with an implant on the contralateral side and extraction of the previous leads due to health insurance coverage issues. Instead, we successfully implanted the RA lead (Medtronic) via incision in the right side and tunnelling to the left pocket of the previous ICD using fluoroscopic guidance. The total fluoroscopy time was 30 min, and the total procedure time was 180 min. A post-procedure chest X-ray confirmed good lead position and no pneumothorax ( Figure 2D) .
The patient was discharged and showed improved LV function, with EF increasing to 40% 6 months later and sinus rhythm with narrow QRS. A routine pacemaker programming visit showed that the condition of the leads was stable and all parameters were normal. The patient's symptoms have also improved.
Discussion
Subclavian vein stenosis/occlusion is a known complication following transvenous cardiac implantable electronic device (CIED) insertion. In case no. 1, venography revealed total subclavian vein occlusion 
with azygos vein collateral drainage with the previous two leads. Careful inspection revealed a tapering stump. In case no. 2, venography demonstrated subclavian vein stenosis with collateral drainage to the internal jugular vein with the previous leads. Only a small volume of blood continued to flow, underscoring the importance of avoiding crowding of the subclavian vein.
Interventions for subclavian and central vein stenosis have been described by Marcial and Worley, 3 and Buiten et al. 4 reviewed use of a lead extraction tool and its complications. However, no optimal step-by-step intervention strategy has been reported yet. Figure 3 presents our proposed treatment algorithm for performing venous intervention combined with new lead implantation. The first step is to reduce the risk of damage to any ipsilateral arteriovenous fistula, if the patient undergoes regular haemodialysis. Central venous stenosis is a frequently encountered problem among dialysis patients. The frequent punctures needed for dialysis also increase the risk of infection. If we implanted leads on the same side of haemodialysis site, there is significant risk of losing the vascular access of haemodialysis. The second step is the routine performance of peripheral venography and careful inspection of the venogram under digital subtraction angiography. If visible flow remains (which means visible blood flow back to RA), the vessel can be directly wired and dilated through the introduction of a large sheath or balloon venoplasty. Advancing the long sheath to bypass the stenotic lesion is critical. A balloon anchoring technique may improve the ease of advancement, as demonstrated in case no. 2. Stenting may be another option if the vessel easily recoils and leads can be extracted totally. The Heart Rhythm Society expert consensus on transvenous lead extraction suggests CIED lead removal should be prior to stent deployment at sites of lead-induced venous stenosis to avoid entrapment of the CIED leads. 5 In cases involving total occlusion as indicated by venography (which is defined by 100% occlusion at subclavian vein or axillary vein, sometimes accompanied with collateral veins), we were still able to use an anterograde approach using strong support (5-Fr sheath or 5-Fr Judkins right catheter). We recommend using an 18-in wire to find micro-channels, especially in cases with a tapering stump (as in case no. 1). After passing the lesion and performing venoplasty, we preferred using a 5-Fr Judkins right catheter in place of the stiff wire for further advancement of the long sheath. The retrograde approach from femoral vein to open the occlusion is also the option. It would also be prudent to evaluate the risk and benefits of extracting if the leads were mobile within the fibrous adhesions, we extracted the lead and performed venoplasty. Any subsequent stenting should be performed after leads are extracted.
If all of the above methods have failed, the contralateral approach combined with pre-sternal tunnelling is another option, as described in case no. 2 . The disadvantages of the tunnel technique include the need for general anaesthesia and the requirement of a longer lead, which is not available in some countries. If all these methods fail, implantation at the opposite or epicardial lead can be also considered. Finally, abandoned CIED leads create a challenging decision-making process when considering extraction. Heart Rhythm Society expert consensus statement suggests several indications. 6 The risks of abandonment include venous stenosis, leadlead interaction, and infection. The sum of the diameter of leads may result in venous stenosis. 7 Clinically significant thromboembolic events related to transvenous leads occur with a low incidence, and no study has directly linked abandoned leads to venous thrombosis. 6 The reasonable maximum number of leads depends on patient's age, with 3-4 leads in the young patient and 5 leads in the older patient. 8 The potential risk of electrical interference between abandoned leads and functional leads is not supported by published research studies, and the exact incidence is unknown. It rarely causes oversensing although leads can rub together causing an insulation break. 5, 6 The correlation between the infection rate and abandoned leads has failed to demonstrate an increased risk of device-related infection, but the evidence is limited by small sample size and short follow-up periods. 5 In addition, patients with CIED infections and previously abandoned leads have distinguishing characteristics in terms of presentation, pathogen, and need for more specialized tools for extraction. 9 To sum up, only those patients in whom the benefits of lead removal outweigh the risks receive leads extraction. It is important to consider the duration the lead has been implanted, the fragility of each particular lead, life expectancy of patients and the experience of operators. 6 Our hospital is a tertiary university hospital with four qualified electrophysiology cardiologists. Annually, our hospital performs about 300 permanent pacemaker implantations, 30 ICDs, and 20 CRT-Ds. A prospective study and registry of these cases are needed to further explore the best strategy for addressing this problem. Cardiac device-related subclavian vein stenosis
